Investors/Media

Investor Relations

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Learn more about our clinical pipeline here.

Corporate Presentation

Stock Information

Change

High

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Events and Presentations

March 2, 2021 at 11:10 AM PST
41st Cowen Annual Healthcare Conference Sign up
February 24, 2021 at 9:00 AM PST
10th Annual SVB Leerink Global Healthcare Conference Sign up